643 - Cefiderocol In vitro Activity Against Molecularly Characterized Pseudomonas aeruginosa and Acinetobacter baumannii-calcoaceticus complex Clinical Isolates Causing Infection in United States Hospitals (2020-2021)

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

CH

Cory Hubler, BS

Molecular Scientist II
JMI Laboratories
North Liberty, Iowa, United States
VK

Valerie Kantro, BA

Molecular Laboratory Manager
JMI Laboratories
North Liberty, Iowa, United States
Dee Shortridge, PhD

Senior Director Microbiology
JMI Laboratories
North Liberty, Iowa, United States
Helio S. Sader, MD, PhD

Senior Director, Microbiology & Surveillance
JMI Laboratories
North Liberty, Iowa, United States
JS

Jennifer M. Streit, BS, MT(ASCP)

Surveillance Manager
JMI Laboratories
North Liberty, Iowa, United States
Mariana Castanheira, PhD

Chief Scientific Officer
JMI Laboratories
North Liberty, Iowa, United States